Abstract
The clinical management of sepsis has benefited from breakthroughs in antimicrobial chemotherapy as well as other pharmacologic and technologic means of critical care support. Despite such advances, the course of patients suffering sepsis remains unpredictable and often protracted [1]. Disruptions of immunologic and metabolic homeostasis are well recognized sequelae of sepsis that contribute to the morbidity and mortality of chronic sepsis. In addition, variables related to the clinical status of patients prior to the onset of sepsis also appear to impact on the acute manifestations of sepsis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
